title: Who should be targeted for vaccination against anal cancer?
authors.affiliation: Department of Obstetrics and Gynecology, Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Lee's Summit Road, Kansas City, MO 64139, USA. diane.m.harper@gmail.com
authors.forename: Diane M
authors.initials: DM
authors.lastname: Harper
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Vierthaler
mesh_terms: D001005:Anus Neoplasms / Q000517:prevention & control*; D005260:Female; D052162:Human papillomavirus 16 / Q000276:immunology*; D052161:Human papillomavirus 18 / Q000276:immunology*; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D011230:Precancerous Conditions / Q000517:prevention & control*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*
chemical_list: D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18